Itamar Medical's Endo-PAT2000 Gains Approval by Australian Government

January 2, 2009 - Itamar Medical, an international medical technology company developing noninvasive diagnostic systems using the peripheral arterial tone (PAT) signal, recently said it received Therapeutic Goods Administration (TGA) clearance for the Endo-PAT2000, certifying its use and distribution in Australia.

Itamar says it developed the first simple, inexpensive, office-based diagnostic test for endothelial function. The Endo-PAT2000 is a noninvasive device that measures endothelial function, the earliest clinically detectable stage of cardiovascular disease, using bio-sensors mounted on patients’ fingers that measure minute changes in vascular tone using Itamar’s PAT signal technology.

For more information: www.itamar-medical.com